Effect of extracorporeal shockwave therapy on spasticity in chronic stroke patients

the phenomenon of spasticity following a stroke and Extracorporeal Shockwave Therapy (ESWT) as a potential treatment option for reducing spasticity in stroke patients. Spasticity is described as a motor disorder resulting from hyperexcitability of the stretch reflex, contributing to functional limitations and negatively impacting recovery.

ESWT is a series of high-energy mechanical waves with characteristics such as pressure, rapid pressure increase, and short action cycle. It is categorised into focused (fESWT) and radial (rESWT) types, each having different penetration depths and applications. The study emphasises ESWT’s ability to induce nitric oxide synthesis, reduce motor neuron excitability, modulate nerve conduction, and affect muscle and soft tissue.

Several studies and findings are referenced to support the claim that ESWT may alleviate limb spasticity after a stroke through mechanisms such as increased nitric oxide production, reduced motor neuron excitability, and modulation of nerve conduction. The text also mentions the impact of ESWT on muscle and soft tissue, suggesting improvements in joint mobility and muscle properties.

The need for further research on the effects of shockwave therapy on spasticity in stroke patients is highlighted. The potential benefits include offering an alternative treatment option, a non-invasive approach, and potentially improving rehabilitation outcomes for stroke survivors.

The study’s aim is stated as determining whether shockwave therapy can effectively reduce spasticity in chronic stroke patients. The objective is to examine if stroke patients receiving shockwave therapy show better mobility and functional capacities, with specific measurements of muscle tone and range of motion. Two hypotheses are presented: a null hypothesis suggesting no significant difference in spasticity reduction with shockwave therapy and an alternate hypothesis proposing a statistically significant difference.

Inclusion criteria for potential study participants are outlined, including a history of stroke, a specified age range, medical stability, presence of spasticity, and willingness to engage in shockwave therapy. Exclusion criteria involve severe cognitive impairments, uncontrolled medical conditions, pre-existing shoulder injuries or surgeries, inability to provide informed consent, and participation in conflicting rehabilitation programs.

The dependent variable in the study is the level of spasticity, while the independent variable is the application of extracorporeal shockwave therapy. The text suggests using the Modified Ashworth Scale and possibly other tools to measure and evaluate the effects of shockwave therapy on spasticity.